These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2887350)

  • 1. Characterization of angiotensin I-converting enzyme activity in the freshwater turtle, Amyda japonica.
    Cho KW; Kim SZ; Kim SH; Koh GY; Seul KH
    Comp Biochem Physiol A Comp Physiol; 1987; 87(3):645-8. PubMed ID: 2887350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril and teprotide as discriminators of angiotensin-converting enzyme activity in brain tissue.
    Zubenko GS; Nixon RA
    Neurosci Lett; 1985 Sep; 60(1):33-7. PubMed ID: 2997673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme substrates hydrolyzed by fibroblasts and vascular endothelial cells.
    Rubin DB; Mason RJ; Dobbs LJ
    Exp Lung Res; 1982 May; 3(2):137-45. PubMed ID: 6179773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From teprotide to captopril. Rational design of ACE inhibitors].
    Nemec K; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2003; 32(1):11-6. PubMed ID: 12577755
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of time and dose on angiotensin converting enzyme during captopril treatment in the rat.
    Forslund T
    Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):201-4. PubMed ID: 6303049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of angiotensin converting enzyme in the rat: effect of captopril treatment.
    Forslund T; Kouvonen I; Fyhrquist F
    Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54(2):124-8. PubMed ID: 6324538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
    Schmidt M; Giesen-Crouse EM; Krieger JP; Welsch C; Imbs JL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S100-5. PubMed ID: 2438482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the renin-angiotensin system in the turtle Pseudemys scripta.
    Cipolle MD; Zehr JE
    Am J Physiol; 1984 Jul; 247(1 Pt 2):R15-23. PubMed ID: 6377928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics, assay and semeiologic value of angiotensin converting enzyme (ACE)].
    Battesti JP; Sandron D; Lecossier D; Basset G
    Ann Biol Clin (Paris); 1982; 40(3):199-203. PubMed ID: 6182819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture.
    Andrade MC; Quinto BM; Carmona AK; Ribas OS; Boim MA; Schor N; Casarini DE
    J Hypertens; 1998 Dec; 16(12 Pt 2):2063-74. PubMed ID: 9886898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of angiotensin-converting enzyme in canine testis.
    Sabeur K; Vo AT; Ball BA
    Reproduction; 2001 Jul; 122(1):139-46. PubMed ID: 11425338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and enzymatic properties of the ram epididymal soluble form of germinal angiotensin I-converting enzyme.
    Métayer S; Dacheux F; Guérin Y; Dacheux JL; Gatti JL
    Biol Reprod; 2001 Nov; 65(5):1332-9. PubMed ID: 11673247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antienzymic activity of two new angiotensin converting enzyme inhibitors.
    Dudkiewicz J; Suska T; Tautt J; Paruszewski R
    Pol J Pharmacol Pharm; 1991; 43(1):33-8. PubMed ID: 1663247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K; Inoue Y; Kokubu T
    Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril.
    Sun Y; Mendelsohn FA
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):478-86. PubMed ID: 1724523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotianamine preferentially inhibits Angiotensin I-converting enzyme.
    Hayashi A; Kimoto K
    J Nutr Sci Vitaminol (Tokyo); 2007 Aug; 53(4):331-6. PubMed ID: 17934238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of specific inhibitors of angiotensin I converting enzyme (kininase II).
    Cushman DW; Cheung HS; Sabo EF; Rubin B; Ondetti MA
    Fed Proc; 1979 Dec; 38(13):2778-82. PubMed ID: 228989
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical and immunological studies of angiotensin converting enzymes from human, bovine, dog, hog, rabbit, rat and sheep kidneys.
    Takada Y; Unno M; Hiwada K; Kokubu T
    Comp Biochem Physiol B; 1982; 73(2):189-94. PubMed ID: 6293756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.